Joining the Fight
Analytical science’s journey towards effective COVID-19 testing and treatment
Matthew Hallam | | Quick Read
A point-of-care approach
Merlin Breuning (Notre Dame) and Jacqueline Linnes (Purdue) are working with their teams to develop methods for rapidly quantifying the COVID-19 immune response using novel lateral flow assay devices. The proposed devices will give high sensitivity and semiquantitative measurement of antibody levels. Why? To give inexpensive, point-of-care tests that make use of innovative membrane immobilization technology and thin-strip, microfluidic diagnostic devices.
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine